Retour
28
Fourchette du Jour
136,45 €
144,31 €
Fourchette 52 Semaines
121,06 €
359,97 €
Volume
781 979
Moyenne 50J / 200J
160,65 €
/
181,77 €
Clôture Précédente
141,74 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 15,3 | 0,2 |
| P/B | 1,8 | 3,0 |
| ROE % | 11,0 | 3,6 |
| Net Margin % | 1,0 | 3,8 |
| Rev Growth 5Y % | 13,1 | 10,0 |
| D/E | 1,0 | 0,2 |
Objectif de Cours des Analystes
Hold
175,64 €
+25.6%
Low: 124,00 €
High: 310,00 €
P/E Prévisionnel
27,74
BPA Prévisionnel
5,04 €
Croissance BPA (est.)
+0,0%
CA Est.
44,85B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
25,38 €
23,65 € – 27,55 €
|
52,76B | 2 |
| FY2029 |
19,10 €
17,80 € – 20,73 €
|
50,20B | 2 |
| FY2028 |
12,34 €
10,37 € – 13,34 €
|
49,27B | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-05 | 0,43 € | -2,75 € | -739,5% |
| 2025-10-22 | 3,97 € | 1,84 € | -53,7% |
| 2025-07-23 | 5,62 € | 5,48 € | -2,5% |
| 2025-04-23 | 5,97 € | 6,08 € | +1,8% |
| 2025-02-05 | 5,74 € | 5,05 € | -12,0% |
| 2024-10-23 | 5,81 € | 6,01 € | +3,4% |
| 2024-07-24 | 5,50 € | 5,86 € | +6,5% |
| 2024-04-24 | 5,59 € | 5,73 € | +2,5% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 13,09% annually over 5 years — strong growth
Earnings declined -59,97% over the past year
ROE of 11,02% — decent returns on equity
Negative free cash flow of -636,00M
Capital efficient — spends only 0,22% of revenue on capex
Croissance
Revenue Growth (5Y)
13,09%
Revenue (1Y)11,75%
Earnings (1Y)-59,97%
FCF Growth (3Y)N/A
Qualité
Return on Equity
11,02%
ROIC7,30%
Net Margin1,04%
Op. Margin1,72%
Sécurité
Debt / Equity
0,97
Current Ratio1,69
Interest Coverage4,07
Valorisation
P/E Ratio
15,26
Forward P/E27,74
P/B Ratio1,77
EV/EBITDA8,84
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,75% | Revenue Growth (3Y) | 15,47% |
| Earnings Growth (1Y) | -59,97% | Earnings Growth (3Y) | -34,23% |
| Revenue Growth (5Y) | 13,09% | Earnings Growth (5Y) | -8,01% |
| Profitability | |||
| Revenue (TTM) | 45,43B | Net Income (TTM) | 472,00M |
| ROE | 11,02% | ROA | 3,03% |
| Gross Margin | 8,97% | Operating Margin | 1,72% |
| Net Margin | 1,04% | Free Cash Flow (TTM) | -636,00M |
| ROIC | 7,30% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,97 | Current Ratio | 1,69 |
| Interest Coverage | 4,07 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 15,26 | Forward P/E | 27,74 |
| P/B Ratio | 1,77 | P/S Ratio | 0,16 |
| PEG Ratio | -0,33 | Forward PEG | N/A |
| EV/EBITDA | 8,84 | Fwd EV/EBITDA | 3,81 |
| Forward P/S | 0,16 | Fwd Earnings Yield | 3,60% |
| FCF Yield | -8,83% | ||
| Market Cap | 7,20B | Enterprise Value | 6,90B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 45,43B | 40,65B | 34,07B | 31,97B | 27,77B |
| Net Income | 472,00M | 1,18B | 1,09B | 792,00M | 659,00M |
| EPS (Diluted) | 8,92 | 20,42 | 18,78 | 13,54 | 11,25 |
| Gross Profit | 4,08B | 4,74B | 4,33B | 3,93B | 3,28B |
| Operating Income | 781,00M | 1,71B | 1,57B | 1,17B | 1,02B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 15,56B | 15,63B | 14,89B | 12,31B | 12,21B |
| Total Liabilities | 11,50B | 11,13B | 10,68B | 9,35B | 9,58B |
| Shareholders' Equity | 4,07B | 4,50B | 4,22B | 2,96B | 2,63B |
| Total Debt | 3,95B | 3,12B | 2,39B | 2,39B | 2,39B |
| Cash & Equivalents | 4,25B | 4,66B | 4,85B | 4,01B | 4,44B |
| Current Assets | 12,44B | 12,77B | 12,54B | 10,08B | 10,06B |
| Current Liabilities | 7,37B | 7,90B | 8,17B | 6,86B | 7,05B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#382 of 619
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026